{
  "title": "Paper_751",
  "abstract": "Nan Fang Yi Ke Da Xue Xue Bao Nan Fang Yi Ke Da Xue Xue Bao 3701 jsouthmed nfykdxxb Journal of Southern Medical University 1673-4254 2663-0842 Editorial Department of Journal of Southern Medical University PMC12479259 PMC12479259.1 12479259 12479259 41022610 10.12122/j.issn.1673-4254.2025.09.20 1673-4254(2025)09-2006-13 1 Research Article MZB1基因在泛癌中的表达及其与免疫浸润及预后的关系 Pan-cancer analysis of MZB1 expression and its association with immune infiltration and clinical prognosis 张 瑜 ZHANG Yu 1 李 海涛 LI Haitao 1 潘 玉卿 PAN Yuqing 2 曹 杰贤 CAO Jiexian 2 翟 丽 ZHAI Li 1 张 曦 ZHANG Xi 1  1 云南省肿瘤医院//昆明医科大学第三附属医院医学检验科 云南 昆明 650118  1 Department of Clinical Laboratory, Cancer Hospital of Yunnan Province, Third Affiliated Hospital of Kunming Medical University Kunming 650118 China  2 昆明医科大学第一附属医院医学检验科//云南省检验医学重点实验室//云南省医学检验临床医学研究中心 云南 昆明 650032  2 Clinical Laboratory, First Affiliated Hospital of Kunming Medical University, Yunnan Key Laboratory of Laboratory Medicine, Yunnan Provincal Clinical Research Center for Laboratory Medicine Kunming 650032 China 经 媛 张 曦 zhangxi@kmmu.edu.cn  张 瑜 15520858743@163.com 20 9 2025 45 9 497824 2006 2018 15 5 2025 20 09 2025 01 10 2025 01 10 2025 2025 版权所有©《南方医科大学学报》编辑部2021 Copyright ©2021 Journal of Southern Medical University. All rights reserved. 目的 探讨边缘区B细胞及B1细胞特异性蛋白（MZB1）在泛癌中的表达水平及其与患者预后、肿瘤微环境的关系。 方法 利用UCSC数据库提取MZB1在33种癌症中的表达数据、临床病理参数和生存数据。利用R软件分析MZB1与临床分期、患者预后、免疫调节基因、免疫检查点基因、肿瘤干性、免疫细胞浸润、肿瘤突变负荷（TMB）以及微卫星不稳定性（MSI）的相关性，使用cBioPortal在线数据库分析MZB1在泛癌中基因突变情况，利用ROC曲线分析MZB1的癌症诊断价值，利用RT-qPCR和Western blotting检测MZB1在髓系白血病和肾癌中的表达，利用EdU法检测干扰MZB1后细胞的增殖情况。 结果 与正常组织相比，MZB1在肾透明细胞癌（KIRC）、乳腺浸润性癌（BRCA）、急性髓系白血病（LAML）等20种肿瘤中高表达（ P P + + P P 结论 MZB1在多种肿瘤中高表达，其异常表达影响多种肿瘤的发生及预后，有望成为新的肿瘤标志物和免疫调节靶点。 Objective To investigate the expression levels of marginal zone B and B1-cell-specific protein (MZB1) in pan-cancer and its association with patient prognosis and tumor microenvironment (TME). Methods MZB1 expression data, clinicopathological parameters, and survival data from 33 cancer types were extracted from the UCSC database for analyzing the correlations of MZB1 with clinical stage, patient prognosis, immunomodulatory genes, immune checkpoint genes, tumor stemness, immune cell infiltration, tumor mutational burden (TMB), and microsatellite instability (MSI). MZB1 gene mutations in pan-cancer were assessed using cBioPortal online database, and the value of MZB1 for cancer diagnosis was evaluated using ROC curve analysis. MZB1 expression levels in myeloid leukemia and renal carcinoma cells were detected using RT-qPCR and Western blotting, and the effect of MZB1 knockdown on cell proliferation was examined using EdU assay. Results MZB1 was significantly overexpressed in 20 cancer types, including kidney renal clear cell carcinoma (KIRC), breast invasive carcinoma, and acute myeloid leukemia. Its expression was associated with TNM stage, clinical stage, overall survival, and progression-free survival in multiple cancers. In most tumors, MZB1 expression was correlated significantly with immunomodulatory genes, immune checkpoint genes, tumor stemness, immune cell infiltration, TMB, and microsatellite instability. Gene amplification was the predominant mutation type of MZB1 in pan-cancer, and MZB1 showed high diagnostic value for skin cutaneous melanoma, KIRC, and head and neck squamous cell carcinoma. MZB1 was highly expressed in different myeloid leukemia cell lines and renal carcinoma cell lines, and MZB1 knockdown significantly suppressed the proliferation of HL60 and 769-P cells. Conclusion MZB1 is highly expressed in a variety of tumors, and its aberrant expression affects the occurrence and prognosis of many tumors, suggesting its potential as a novel tumor biomarker and immunomodulatory target. MZB1 泛癌分析 免疫浸润 预后 治疗靶点 marginal zone B and B1-cell-specific protein pan-cancer analysis immune infiltration prognosis therapeutic target 云南省教育厅科学研究基金项目 2024J0330 2025J0247 云南省应用基础研究计划 202101AY070001-165 云南省临床医学研究中心子课题 202102AA100063-06 pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access no pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes ",
  "metadata": {
    "Title of this paper": "MZB1基因在泛癌中的表达及其与免疫浸润及预后的关系",
    "Journal it was published in:": "Journal of Southern Medical University",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12479259/"
  }
}